Back to search

Article

Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L

2021-10-20

Abstract excerpt

There are currently no FDA approved inhibitors of SARS-CoV-2 viral proteases with specific treatment for post-exposure of SARS-CoV-2. Here, we discovered inhibitors containing thiuram disulfide or dithiobis-(thioformate) tested against three key proteases in SARS CoV-2 replication including SARS CoV-2 Main Protease (Mpro), SARS CoV-2 Papain Like Protease (PLpro), and human cathepsin L. The use of thiuram disulfide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3fed6718-1d6a-5b70-808a-09bdd4f096e4
DOI
10.1101/2021.10.19.465036
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin LDOI 10.1101/2021.10.19.465036
Select a neighboring publication to make it the new centre.